Playback speed
10 seconds
ASCO 2022 PACIFIC Trial Updates: Response Kinetics, Safety & Efficacy of Brentuximab Vedotin & Nivolumab +/- R-CHP for Untreated PMBL
By
ASCO 2022 Conference Coverage
FEATURING
Raphael Steiner
By
ASCO 2022 Conference Coverage
FEATURING
Raphael Steiner
405 views
June 7, 2022
Login to view comments.
Click here to Login